{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T19:13:04Z","timestamp":1774811584632,"version":"3.50.1"},"reference-count":28,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":1071,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,13]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives and importance of study:<\/jats:title>\n                    <jats:p>Changing cancer screening programs is notoriously difficult and may be influenced by clinicians\u2019 willingness to adhere to new guidelines. Our objective was to investigate clinicians\u2019 adherence to revised cervical screening guidelines and to identify any reasons for testing outside the revised guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Australian clinicians involved in cervical screening and treating women with cervical abnormalities were invited to complete a cross-sectional online survey between September 2019 and February 2020. We measured self-reported adherence to cervical screening guidelines for three common scenarios and analysed free-text reasons for offering tests contrary to guidelines using content analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 607 clinicians (283 general practitioners [GPs], and 324 obstetricians and gynaecologists [O&amp;Gs]) were eligible and participated. Of these, 37.8% of GPs and 43.8% of O&amp;Gs would provide testing more frequently than indicated by guidelines, but recognised the need for patients to be aware of the additional cost and for guidelines to be explained; 13.9% of GPs and 10.2% of O&amp;Gs would screen women at a younger age than indicated due to patient request, patient\/family history and the need for patient reassurance; and 11.4% of GPs and 23.6% of O&amp;Gs would perform a HPV and cytology co-test when not indicated, mainly as a result of a mistake or lack of familiarity with guidelines, patient\/family history and patient reassurance. Patient request for testing was a reason for testing outside the guidelines with regard to frequency of testing, age of testing and co-testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These data suggest that it is likely cervical screening outside guidelines is occurring in Australia. As patients often request these tests, strategies to reduce screening outside the guidelines should include ensuring that women are aware of the financial implications and the reasons for the updated guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.17061\/phrp3242237","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T17:23:16Z","timestamp":1670779396000},"source":"Crossref","is-referenced-by-count":1,"title":["Reasons that clinicians in Australia offer cervical screening outside guidelines for frequency, age and co-testing"],"prefix":"10.1071","volume":"32","author":[{"given":"Rachael","family":"Dodd","sequence":"first","affiliation":[{"name":"A Faculty of Medicine and Health, School of Public Health, University of Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Obermair","sequence":"additional","affiliation":[{"name":"A Faculty of Medicine and Health, School of Public Health, University of Sydney, NSW, Australia"},{"name":"B Department of Obstetrics & Gynaecology, Royal North Shore Hospital, St Leonards, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"McCaffery","sequence":"additional","affiliation":[{"name":"A Faculty of Medicine and Health, School of Public Health, University of Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"2026011323571063800_R1","doi-asserted-by":"crossref","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review panel on breast cancer screening. Br J Cancer. 2013;108(11):2205\u201340. CrossRef | PubMed","DOI":"10.1038\/bjc.2013.177"},{"key":"2026011323571063800_R2","doi-asserted-by":"crossref","unstructured":"Carter SM, Barratt A. What is overdiagnosis and why should we take it seriously in cancer screening? Public Heal Res Pract. 2017;27(3):e2731722. CrossRef | PubMed","DOI":"10.17061\/phrp2731722"},{"key":"2026011323571063800_R3","doi-asserted-by":"crossref","unstructured":"Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337(7673):798-803. CrossRef | PubMed","DOI":"10.1136\/bmj.a1284"},{"key":"2026011323571063800_R4","doi-asserted-by":"crossref","unstructured":"Kyrgiou M, Athanasiou A, Kalliala I, Paraskevaidi M, Mitra A, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev. 2017;11(CD012847). CrossRef","DOI":"10.1002\/14651858.CD012847"},{"key":"2026011323571063800_R5","doi-asserted-by":"crossref","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489\u201398. CrossRef","DOI":"10.1016\/S0140-6736(06)68181-6"},{"key":"2026011323571063800_R6","doi-asserted-by":"crossref","unstructured":"Gerend MA, Shepherd MA, Kaltz EA, Davis WJ, Shepherd JE. Understanding women\u2019s hesitancy to undergo less frequent cervical cancer screening. Prev Med (Baltim). 2017;95:96\u2013102. CrossRef | PubMed","DOI":"10.1016\/j.ypmed.2016.11.028"},{"key":"2026011323571063800_R7","doi-asserted-by":"crossref","unstructured":"Obermair H, Dodd R, Jansen J, Bonner C, McCaffery KJ. \u201cIt has saved thousands of lives, so why change it?\u201d content analysis of objections to cervical screening programme changes in Australia. BMJ Open. 2018;8(2):e019171. CrossRef | PubMed","DOI":"10.1136\/bmjopen-2017-019171"},{"key":"2026011323571063800_R8","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2019. Canberra: AIHW; 2019. [cited 2021 Jun 1]. Available from: www.aihw.gov.au\/reports\/cancer-screening\/cervical-screening-in-australia-2019\/summary"},{"key":"2026011323571063800_R9","doi-asserted-by":"crossref","unstructured":"Brotherton JM, Gertig DM, May C, Chappell G, Saville M. HPV vaccine impact in Australian women: ready for an HPV-based screening program. Med J Aust. 2016;204(5):184. CrossRef | PubMed","DOI":"10.5694\/mja15.01038"},{"key":"2026011323571063800_R10","unstructured":"Medical Services Advisory Committee. Application No. 1276 \u2013 Renewal of the national cervical screening program. Canberra: Australian Government MSAC; 2013. [cited 2021 June 1]. Available from: www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/D924E2F768B13C4BCA25801000123B9E\/$File\/1276%20-%20Final%20MSAC%20PSD%20-%20NCSP%20Renewal.pdf"},{"key":"2026011323571063800_R11","doi-asserted-by":"crossref","unstructured":"Boone E, Lewis L, Karp M. Discontent and confusion: primary care providers\u2019 opinions and understanding of current cervical cancer screening recommendations. J Women\u2019s Heal. 2016;25(3):255\u201362. CrossRef | PubMed","DOI":"10.1089\/jwh.2015.5326"},{"key":"2026011323571063800_R12","doi-asserted-by":"crossref","unstructured":"Min CJ, Massad LS, Dick R, Powell MA, Kuroki LM. Assessing physician adherence to guidelines for cervical cancer screening and management of abnormal screening results. J Low Genit Tract Dis. 2020;24(4):337\u201342. CrossRef | PubMed","DOI":"10.1097\/LGT.0000000000000558"},{"key":"2026011323571063800_R13","doi-asserted-by":"crossref","unstructured":"Caglioti C, Pileggi C, Nobile CGA, Pavia M. Gynecologists and human papillomavirus DNA testing. Eur J Cancer Prev. 2017;26(3):249\u201356. CrossRef | PubMed","DOI":"10.1097\/CEJ.0000000000000325"},{"key":"2026011323571063800_R14","doi-asserted-by":"crossref","unstructured":"Tatar O, Wade K, McBride E, Thompson E, Head KJ, Perez S, et al. Are health care professionals prepared to implement human papillomavirus testing? A review of psychosocial determinants of human papillomavirus test acceptability in primary cervical cancer screening. J Women\u2019s Heal. 2019;29(3):390\u2013405. CrossRef | PubMed","DOI":"10.1089\/jwh.2019.7678"},{"key":"2026011323571063800_R15","unstructured":"Symonds C, Chen W, Rose M, Cooke L. Screening with Papanicolaou tests in Alberta. Are we choosing wisely? Can Fam Physician. 2018;64(1):47\u201353. PubMed"},{"key":"2026011323571063800_R16","doi-asserted-by":"crossref","unstructured":"Yap D, Liang X, Garland SM, Hartley S, Gorelik A, Ogilvie G, et al. Clinicians\u2019 attitude towards changes in Australian national cervical screening program. J Clin Virol. 2016;76:S81\u20137. CrossRef | PubMed","DOI":"10.1016\/j.jcv.2015.11.018"},{"key":"2026011323571063800_R17","doi-asserted-by":"crossref","unstructured":"Obermair H, Bennett K, McCaffery K, Brotherton J, Smith M, Dodd R. Australian national cervical screening program renewal: attitudes and experiences of general practitioners, and obstetricians and gynaecologists. Aust New Zeal J Obstet Gynaecol. 2021;61(3):416\u2013423. CrossRef | PubMed","DOI":"10.1111\/ajo.13310"},{"key":"2026011323571063800_R18","doi-asserted-by":"crossref","unstructured":"Weber RP. Content Analysis. In: Basic Content Analysis. 2nd ed. London: Sage; 1990. p.117\u2013124. CrossRef","DOI":"10.4135\/9781412983488"},{"key":"2026011323571063800_R19","doi-asserted-by":"crossref","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37\u201346. CrossRef","DOI":"10.1177\/001316446002000104"},{"key":"2026011323571063800_R20","doi-asserted-by":"crossref","unstructured":"Dodd RH, Obermair HM, McCaffery KJ. Implementing changes to cervical screening: A qualitative study with health professionals. Aust New Zeal J Obstet Gynaecol. 2020;60(5):776\u201383. CrossRef | PubMed","DOI":"10.1111\/ajo.13200"},{"key":"2026011323571063800_R21","doi-asserted-by":"crossref","unstructured":"Perkins RB, Anderson BL, Gorin SS, Schulkin JA. Challenges in cervical cancer prevention a survey of U.S. obstetrician-gynecologists. Am J Prev Med. 2013;45(2):175\u201381. CrossRef | PubMed","DOI":"10.1016\/j.amepre.2013.03.019"},{"key":"2026011323571063800_R22","doi-asserted-by":"crossref","unstructured":"Teoh D, Marriott A, Vogel R, Marriott RT, Lais CW, Downs LS, et al. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. Am J Obstet Gynecol. 2015;212(1):62.e1\u201362.e9. CrossRef | PubMed","DOI":"10.1016\/j.ajog.2014.06.057"},{"key":"2026011323571063800_R23","doi-asserted-by":"crossref","unstructured":"Dodd R, Nickel B, Wortley S, Bonner C, Hersch J, McCaffery K. Examining the information needed for acceptance of deintensified screening programmes: qualitative focus groups about cervical screening in Australia. BMJ Open. 2019;9:e029319. CrossRef | PubMed","DOI":"10.1136\/bmjopen-2019-029319"},{"key":"2026011323571063800_R24","doi-asserted-by":"crossref","unstructured":"Obermair HM, McCaffery KJ, Dodd RH. \u201cA Pap smear saved my life\u201d: Personal experiences of cervical abnormalities shape attitudes to cervical screening renewal. J Med Screen. 2020;27(4):223\u20136. CrossRef | PubMed","DOI":"10.1177\/0969141319889648"},{"key":"2026011323571063800_R25","doi-asserted-by":"crossref","unstructured":"Munro A, Spilsbury K, Leung Y, O\u2019Leary P, Williams V, Codde J, et al. The human papillomavirus test of cure: a lesson on compliance with the NHMRC guidelines on screening to prevent cervical cancer. Aust New Zeal J Obstet Gynaecol. 2015;55(2):185\u201390. CrossRef | PubMed","DOI":"10.1111\/ajo.12309"},{"key":"2026011323571063800_R26","doi-asserted-by":"crossref","unstructured":"Dodd RH, Mac O, Brotherton JML, Cvejic E, McCaffery KJ. Levels of anxiety and distress following receipt of positive screening tests in Australia\u2019s HPV-based cervical screening programme: A cross-sectional survey. Sex Transm Infect. 2020;96(3):166\u201372. CrossRef | PubMed","DOI":"10.1136\/sextrans-2019-054290"},{"key":"2026011323571063800_R27","doi-asserted-by":"crossref","unstructured":"Sirovich B, Woloshin S, Schwartz L. Screening for cervical cancer: will women accept less? Am J Med. 2005;118:151\u20138. CrossRef | PubMed","DOI":"10.1016\/j.amjmed.2004.08.021"},{"key":"2026011323571063800_R28","doi-asserted-by":"crossref","unstructured":"Mathias JS, Gossett D, Baker DW. Use of electronic health record data to evaluate overuse of cervical cancer screening. J Am Med Informatics Assoc. 2012;19(E1):96\u2013101. CrossRef | PubMed","DOI":"10.1136\/amiajnl-2011-000536"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp3242237\/1822190\/pu19395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp3242237\/1822190\/pu19395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:57:19Z","timestamp":1768366639000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/32\/4\/e3242237\/265376\/Reasons-that-clinicians-in-Australia-offer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.17061\/phrp3242237","relation":{},"ISSN":["2204-2091"],"issn-type":[{"value":"2204-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"article-number":"e3242237"}}